PTC Therapeutics to Participate at Upcoming Investor Conference
PTC Therapeutics to Participate at Upcoming Investor Conference
WARREN, N.J., May 29, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference:
新澤西州禾倫，2024年5月29日 /PRNewswire/ — PTC Therapeutics, Inc.（納斯達克股票代碼：PTCT）今天宣佈，該公司將在以下會議上介紹公司概況：
William Blair's 44th Annual Growth Stock Conference
Tuesday, June 4, at 9:00 am ET / 8:00 am CT
威廉·布萊爾的第 44 屆年度成長股會議
美國東部時間6月4日星期二上午9點/美國中部時間上午8點
The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
該演示將在PTC Therapeutics網站投資者部分下方的活動和演示頁面上進行網絡直播，並將在演示結束後存檔30天。建議用戶在網絡直播開始前幾分鐘連接到 PTC 的網站，以確保及時連接。
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at and follow us on Instagram, Facebook, Twitter, and LinkedIn.
關於 PTC Therapeutics, Inc.
PTC是一家全球生物製藥公司，專注於臨床差異化藥物的發現、開發和商業化，爲罕見疾病患者帶來益處。PTC在全球範圍內實現產品商業化的能力是推動對強大而多元化的變革性藥物管道的投資的基礎，也是我們的使命是爲醫療需求未得到滿足的患者提供一流治療的機會。該公司的戰略是利用其強大的科學專業知識和全球商業基礎設施，爲患者和其他利益相關者實現價值最大化。要了解有關PTC的更多信息，請訪問我們並在Instagram、臉書、推特和領英上關注我們。
For More Information:
欲了解更多信息：
Investors:
Kylie O'Keefe
+1 (908) 300-0691
[email protected]
投資者：
Kylie O'Keefe
+1 (908) 300-0691
[電子郵件保護]
Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]
媒體：
珍妮·克萊門特
+1 (908) 912-9406
[電子郵件保護]
SOURCE PTC Therapeutics, Inc.
來源 PTC Therapeutics, Inc.
譯文內容由第三人軟體翻譯。